Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
The original version of this Article omitted the following from the Acknowledgements: ‘This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program under Award No. W81XWH-15-1-0692. Opinions, interpretations, conclusions a...
Saved in:
Main Authors: | Raffaella Rossin, Ron M. Versteegen, Jeremy Wu, Alisher Khasanov, Hans J. Wessels, Erik J. Steenbergen, Wolter ten Hoeve, Henk M. Janssen, Arthur H. A. M. van Onzen, Peter J. Hudson, Marc S. Robillard |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/fea92d6bbdb8481183adf2d4a9442582 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
by: Raffaella Rossin, et al.
Published: (2018) -
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
by: Wenyan Fu, et al.
Published: (2019) -
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
by: Yinghua Zhao, et al.
Published: (2016) -
Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
by: Rodrigo Vazquez-Lombardi, et al.
Published: (2017) -
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
by: Christopher S. Lunde, et al.
Published: (2019)